Brian A. Fallon, Nevena Zubcevik et al. published an article in Frontiers in Medicine, December 6, 2019, The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease.
Conclusions and Relevance of the study:
“The GSQ-30 is a valid and reliable instrument to assess symptom burden among patients with acute and post-treatment Lyme disease syndrome and is sensitive in the detection of change after treatment among patients with erythema migrans. The GSQ-30 should prove useful in clinical and research settings to assess multi-system symptom burden and to monitor change over time. The GSQ-30 may also prove useful in future precision medicine studies as a clinical measure to correlate with disease-relevant biomarkers.”
Dr. Fallon received LDA grant support for the project, and the resultant publication is the 52nd peer reviewed publication which focuses on LDA-supported research.